Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Autolus Therapeutics plc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 120 | 111 | −9 |
| Shares | 175.7M | 178.2M | +2.50M (+1.4%) |
| Value | $1.12B | $620.0M | −$500.6M (−44.7%) |
New holders (15)
Institutions that held Autolus Therapeutics plc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exome Asset Management LLC | 839,472 | $2.92M | 2.60% |
| Eversept Partners, LP | 610,902 | $2.13M | 0.16% |
| Prelude Capital Management, LLC | 266,692 | $928.1K | 0.08% |
| Vontobel Holding Ltd. | 207,097 | $720.7K | 0.00% |
| Rafferty Asset Management, LLC | 99,319 | $345.6K | 0.00% |
| Clearstead Advisors, LLC | 96,107 | $334.5K | 0.01% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 74,398 | $258.9K | 0.00% |
| Legal & General Group Plc | 60,512 | $210.9K | 0.00% |
| Handelsbanken Fonder AB | 56,000 | $195.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 27,395 | $95.0K | 0.01% |
| Squarepoint Ops LLC | 20,589 | $71.7K | 0.00% |
| Virtus ETF Advisers LLC | 19,984 | $69.5K | 0.03% |
| ProShare Advisors LLC | 12,313 | $42.8K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 5,955 | $19.8K | 0.00% |
| Itau Unibanco Holding S.A. | 3,763 | $13.1K | 0.00% |
Sold out (24)
Institutions that held Autolus Therapeutics plc at the end of Q1 2024 and filed for Q2 2024 without it.